Virtual Medical Academy

Overview

Communicate Mounjaro value proposition and its use in day-to-day practice for people with type 2 Diabetes and Obesity.

This Activity for

Podiatry
Clinical Nutrition
Nursing and Midwifery
Resident / Fellow
Physician
Pharmacy
Clinical Pharmacy
Cardiac Perfusion

What I will learn?

• Discuss the latest guidelines and recommendations for obesity management from leading health organizations such as the American Diabetes Association (ADA) and the World Health Organization (WHO).

• Describe the appropriate patient selection criteria for new emerging weight management agents

• Examine the clinical data that supports the use of GIP/GLP-1 receptor agonists in treatment of type 2 diabetes especially in overweight patients.

•Illustrate the available strategies of how to manage the side effects of new emerging therapeutic agent during the dose-escalation period.

• Interpret the latest clinical trial data concerning safety and efficacy of new emerging therapeutic agents indicated for management of weight gain.

• Define the unique mechanism of action and dual benefits of GIP/GLP-1 receptor agonists in regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.

• Interpret the latest updated guidelines and recommendations concerning the new emerging therapeutic agents that are indicated for regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.